R P Malone

Summary

Affiliation: Drexel University
Country: USA

Publications

  1. ncbi request reprint A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder
    R P Malone
    Department of Psychiatry, MCP Hahnemann University, Philadelphia, PA 19129, USA
    Arch Gen Psychiatry 57:649-54. 2000
  2. ncbi request reprint Olanzapine versus haloperidol in children with autistic disorder: an open pilot study
    R P Malone
    MCP Hahnemann University, Philadelphia, Biomedical Statistical Consulting, Wynnewood, PA, USA
    J Am Acad Child Adolesc Psychiatry 40:887-94. 2001
  3. ncbi request reprint Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness
    Richard P Malone
    MCP Hahnemann University, Philadelphia, PA, USA
    J Am Acad Child Adolesc Psychiatry 41:140-7. 2002
  4. doi request reprint Abnormal movements with the addition of clindamycin to risperidone in a girl with autism
    Richard P Malone
    J Child Adolesc Psychopharmacol 18:221-2. 2008
  5. ncbi request reprint Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II
    Elizabeth Pappadopulos
    Columbia University, New York, NY, USA
    J Am Acad Child Adolesc Psychiatry 42:145-61. 2003
  6. ncbi request reprint Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders
    Richard P Malone
    Department of Psychiatry, Drexel University College of Medicine, Philadelphia, PA 19124 8358, USA
    CNS Drugs 19:923-34. 2005
  7. ncbi request reprint Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies
    Peter S Jensen
    Center for the Advancement of Children s Mental Health, Columbia University NYSPI 1051 Riverside Drive, Unit 78, New York, NY 10032, USA
    J Am Acad Child Adolesc Psychiatry 46:309-22. 2007
  8. doi request reprint Ziprasidone in adolescents with autism: an open-label pilot study
    Richard P Malone
    Department of Psychiatry, Drexel University College of Medicine, 4641 Roosevelt Boulevard, Philadelphia, PA 19124, USA
    J Child Adolesc Psychopharmacol 17:779-90. 2007

Collaborators

Detail Information

Publications8

  1. ncbi request reprint A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder
    R P Malone
    Department of Psychiatry, MCP Hahnemann University, Philadelphia, PA 19129, USA
    Arch Gen Psychiatry 57:649-54. 2000
    ..Our study was designed to critically assess the efficacy of lithium in the treatment of aggression in children and adolescents using a measure specific for aggression...
  2. ncbi request reprint Olanzapine versus haloperidol in children with autistic disorder: an open pilot study
    R P Malone
    MCP Hahnemann University, Philadelphia, Biomedical Statistical Consulting, Wynnewood, PA, USA
    J Am Acad Child Adolesc Psychiatry 40:887-94. 2001
    ..Mean final dosages were 7.9+/-2.5 mg/day for olanzapine and 1.4+/-0.7 mg/day for haloperidol. Outcome measures included the Clinical Global Impressions (CGI) and the Children's Psychiatric Rating Scale (CPRS)...
  3. ncbi request reprint Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness
    Richard P Malone
    MCP Hahnemann University, Philadelphia, PA, USA
    J Am Acad Child Adolesc Psychiatry 41:140-7. 2002
    ..Many clinicians believe that risperidone will not induce dyskinesias in children. The authors investigated open risperidone treatment in children with autism and included findings on dyskinesias...
  4. doi request reprint Abnormal movements with the addition of clindamycin to risperidone in a girl with autism
    Richard P Malone
    J Child Adolesc Psychopharmacol 18:221-2. 2008
  5. ncbi request reprint Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II
    Elizabeth Pappadopulos
    Columbia University, New York, NY, USA
    J Am Acad Child Adolesc Psychiatry 42:145-61. 2003
    ..To develop treatment recommendations for the use of antipsychotic medications for children and adolescents with serious psychiatric disorders and externalizing behavior problems...
  6. ncbi request reprint Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders
    Richard P Malone
    Department of Psychiatry, Drexel University College of Medicine, Philadelphia, PA 19124 8358, USA
    CNS Drugs 19:923-34. 2005
    ..In autism, alternative treatments have also been used, but none have shown benefit in well-designed studies...
  7. ncbi request reprint Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies
    Peter S Jensen
    Center for the Advancement of Children s Mental Health, Columbia University NYSPI 1051 Riverside Drive, Unit 78, New York, NY 10032, USA
    J Am Acad Child Adolesc Psychiatry 46:309-22. 2007
    ..If so, how should IA be assessed, pharmacological studies designed, and ethical issues addressed?..
  8. doi request reprint Ziprasidone in adolescents with autism: an open-label pilot study
    Richard P Malone
    Department of Psychiatry, Drexel University College of Medicine, 4641 Roosevelt Boulevard, Philadelphia, PA 19124, USA
    J Child Adolesc Psychopharmacol 17:779-90. 2007
    ..The purpose of this study was to collect pilot data on the efficacy and safety of ziprasidone in adolescents with autism, focusing on safety issues of weight gain and QTc...